Gibbs Cancer Center and Research Institute Spartanburg

Spartanburg, South Carolina 29303

0 studies enrolling now · 3 studies all time

What they study most

Adjuvant, Advanced Solid Tumors, EGFR, Early Stage Lung Cancer, Exon 20, KRAS p.G12C Mutant Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation, Lung Cancer, NSCLC, Stage IB-IIIA, Post-surgical, Uncommon EGFR Mutations

Studies at this site

• A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) — Completed
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) — Running, not enrolling